A detailed history of Signaturefd, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 247 shares of AUPH stock, worth $1,968. This represents 0.0% of its overall portfolio holdings.

Number of Shares
247
Previous 179 37.99%
Holding current value
$1,968
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$6.75 - $10.44 $459 - $709
68 Added 37.99%
247 $2,000
Q2 2024

Jul 29, 2024

BUY
$4.81 - $5.78 $860 - $1,034
179 New
179 $1,000
Q4 2022

Jan 27, 2023

BUY
$4.11 - $8.14 $86 - $170
21 Added 67.74%
52 $0
Q3 2022

Nov 08, 2022

BUY
$6.66 - $12.39 $206 - $384
31 New
31 $0
Q1 2022

May 02, 2022

SELL
$10.05 - $22.48 $1,407 - $3,147
-140 Closed
0 $0
Q4 2021

Jan 25, 2022

BUY
$17.78 - $33.08 $2,489 - $4,631
140 New
140 $3,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.13B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.